A new case report published in Clinical Neurophysiology describes the first known administration of psilocybin—a psychedelic ...

A new study finds that psilocybin — a psychedelic compound in certain mushrooms — can improve mood, cognitive function, and motor symptoms in people with Parkinson’s disease.

After a rejected psilocybin measure, some still push for its mental health benefits. Hear one couple’s story on the Love ...

Harm caused by repeated concussions, especially in the context of sports, has gained attention in both research and the media ...

A new pilot study reveals that psilocybin—the compound found in psychedelic mushrooms—may significantly improve mood, ...

Use of psilocybin has increased among all age groups since some states decriminalized the hallucinogen in 2019.

New research reveals that psychedelics like psilocybin do more than alter brain activity — they reshape how the brain and immune system communicate.

Increase seen in lifetime use among adults and adolescents; past-year use higher among young adults, older adults.

Psilocybin is the compound in magic mushrooms that is legal for research in Canada and some states in the US. Just one dose ...

The prevalence of lifetime and past-year use of psilocybin increased from 2019 to 2023 among all age groups in the United States.

In the midst of a statewide and national debate about the clinical use of psilocybin, Sean Schriver thinks of two people in ...

Colorado lawmakers are considering legislation that would charge the state health agency to collect data and information on ...